scholarly journals 54: Ovarian reserve after uterine artery embolization in women with morbidly adherent placenta

2018 ◽  
Vol 218 (1) ◽  
pp. S41 ◽  
Author(s):  
Aya Mohr Sasson ◽  
Maya Spira ◽  
Rony Rahav ◽  
Dafna Manela ◽  
Eyal Schiff ◽  
...  
PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0208139 ◽  
Author(s):  
Aya Mohr—Sasson ◽  
Maya Spira ◽  
Rony Rahav ◽  
Dafna Manela ◽  
Eyal Schiff ◽  
...  

2019 ◽  
Vol 99 (1) ◽  
pp. 16-23 ◽  
Author(s):  
Tarek El Shamy ◽  
Saad A. K. Amer ◽  
Ahmed A. Mohamed ◽  
Cathryn James ◽  
Kannamannadiar Jayaprakasan

2002 ◽  
Vol 78 (1) ◽  
pp. 197-198 ◽  
Author(s):  
Togas Tulandi ◽  
Aref Sammour ◽  
David Valenti ◽  
Timothy J. Child ◽  
Laurent Seti ◽  
...  

2020 ◽  
Vol 19 (3) ◽  
pp. 22-29
Author(s):  
B.M. Sharafutdinov ◽  
◽  
E.Yu. Antropova ◽  
M.I. Mazitova ◽  
I.V. Klyucharov ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Devin D. Smith ◽  
Annette Perez-Delboy ◽  
William M. Burke ◽  
Ana I. Tergas

Background. Morbidly adherent placenta (MAP) is increasing in incidence and is commonly associated with maternal hemorrhage and cesarean hysterectomy. Uterine artery embolization (UAE) may be utilized in the conservative management of placenta percreta to potentially reduce blood loss. The incidence of complications from UAE in the conservative management of placenta percreta is poorly described. To our knowledge, we present the first reported case of buttock necrosis in this setting. Case. A 39-year-old gravida nine para two with placenta percreta who underwent conservative management with UAE complicated by right buttock necrosis. Conclusion. While UAE may potentially decrease blood loss, it is not without risk. More studies must be performed in order to quantify those risks and determine the clinical utility of UAE.


2004 ◽  
Vol 81 (4) ◽  
pp. 1055-1061 ◽  
Author(s):  
Giovanna Tropeano ◽  
Carmine Di Stasi ◽  
Katarzyna Litwicka ◽  
Domenico Romano ◽  
Gaetano Draisci ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document